RecruitingPhase 2NCT05004610

Hypertonic Lactate After Cardiac Arrest

Sponsor

Erasme University Hospital

Enrollment

125 participants

Start Date

Feb 19, 2025

Study Type

INTERVENTIONAL

Conditions

Cardiac Arrest Ischemia Reperfusion Injury Anoxic Brain Injury

Summary

The study is intended to test the hypothesis that sodium lactate infusion after resuscitation from a cardiac arrest will decrease the magnitude of brain damage, as measured by the serum biomarker concentration of NSE.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Sodium Lactate Solution for people with anoxic brain injury, cardiac arrest, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGSodium Lactate Solution

continuous intravenous infusion of molar sodium lactate

Locations(1)

Erasme Hospital, Brussels University Hospital (HUB)

Brussels, Belgium, Belgium

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05004610

Related Trials

Initial Double Sequential External Defibrillation in Out of Hospital Cardiac Arrest

NCT066721591 location

AI-powered ECG Analysis Using Willem™ Software in High-risk Cardiac Patients (WILLEM)

NCT0589071613 locations

Avoiding Recooling After Normothermic Machine Perfusion in Liver Transplantation

NCT0769249014 locations

Removing Surrogates Uncertainty to Reduce Fear and Anxiety After Cardiac Events - Kids

NCT077070371 location

A Study to Evaluate the Efficacy and Safety of BX-001N in Preventing Cardiac Surgery-Associated Acute Kidney Injury (CSA-AKI) and Major Adverse Kidney Events (MAKE)

NCT071648338 locations